Assenagon Asset Management’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-15,831
| Closed | -$29.7K | – | 1432 |
|
|
2023
Q4 | $29.7K | Hold |
15,831
| – | – | ﹤0.01% | 1341 |
|
|
2023
Q3 | $26.4K | Sell |
15,831
-13,220
| -46% | -$22.1K | ﹤0.01% | 1323 |
|
|
2023
Q2 | $69.4K | Buy |
29,051
+11,715
| +68% | +$28K | ﹤0.01% | 1262 |
|
|
2023
Q1 | $54.3K | Hold |
17,336
| – | – | ﹤0.01% | 1350 |
|
|
2022
Q4 | $46K | Sell |
17,336
-41,053
| -70% | -$109K | ﹤0.01% | 1285 |
|
|
2022
Q3 | $173K | Hold |
58,389
| – | – | ﹤0.01% | 1236 |
|
|
2022
Q2 | $171K | Buy |
58,389
+14,648
| +33% | +$42.9K | ﹤0.01% | 1345 |
|
|
2022
Q1 | $224K | Buy |
+43,741
| New | +$224K | ﹤0.01% | 1291 |
|